Immune dysregulation in fibromyalgia: Targeting the NLRP3 inflammasome-ferroptosis axis as a novel therapeutic strategy for chronic pain

Clinical Immunology 2026

View at publisher
Authors: Mohamed N Fawzy, Ghada A. Badawi, Rehab M. El-Sayed
DOI: 10.1016/j.clim.2026.110704
Cited by: 6
References: 195

Fields of Study & Subjects

Fibromyalgia and Chronic Fatigue Syndrome Research Ferroptosis and cancer prognosis Osteoarthritis Treatment and Mechanisms

Publication details

Journal / source
Clinical Immunology
Publisher
Elsevier BV
Volume
285
Pages
110704–110704
Publication date
8 April 2026
Language
EN